Phase I trial of ZIO-101 [darinaparsin] in hematologic cancers

Trial Profile

Phase I trial of ZIO-101 [darinaparsin] in hematologic cancers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Darinaparsin (Primary)
  • Indications Leukaemia; Lymphoma; Lymphoproliferative disorders; Multiple myeloma; Myeloproliferative disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jul 2012 Actual end date changed from Jun 2006 to Jun 2008 as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top